Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Klaus Berek

Showing results (71-80 of 95) with videos related to

Pageof 10
Sort By:
European Journal of Neurology|April 30, 2025
Short-Term Risk Factors for Bone Loss in Multiple Sclerosis: A Prospective Study and Literature ReviewAnne Zinganell, Harald Hegen, Janette Walde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2025
Kappa free light chain index predicts long-term disease activity and disability accrual in multiple sclerosisKlaus Berek, Martin Schmidauer, Gabriel Bsteh, et al.
Ebiomedicine|April 22, 2023
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort studyHarald Hegen, Klaus Berek, Gabriel Bsteh, et al.
Frontiers in Immunology|June 29, 2023
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serumKlaus Berek, Angelika Bauer, Dagmar Rudzki, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|March 11, 2009
[Transdermal rivastigmine patch in outpatient services in Austria: a naturalistic study in 103 patients with Alzheimer dementia]Reinhold Schmidt, Claude Alf, Christian Bancher, et al.
Neurology|July 3, 2023
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple SclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
European Journal of Neurology|January 31, 2023
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Multiple Sclerosis and Related Disorders|April 25, 2023
Screening for osteoporosis in people with MS: A new risk scoreAnne Zinganell, Harald Hegen, Janette Walde, et al.
Annals of Clinical and Translational Neurology|December 17, 2024
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical thresholdGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 7, 2024
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining conceptGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
European Journal of Neurology|April 30, 2025
Short-Term Risk Factors for Bone Loss in Multiple Sclerosis: A Prospective Study and Literature ReviewAnne Zinganell, Harald Hegen, Janette Walde, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 16, 2025
Kappa free light chain index predicts long-term disease activity and disability accrual in multiple sclerosisKlaus Berek, Martin Schmidauer, Gabriel Bsteh, et al.
Ebiomedicine|April 22, 2023
Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort studyHarald Hegen, Klaus Berek, Gabriel Bsteh, et al.
Frontiers in Immunology|June 29, 2023
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serumKlaus Berek, Angelika Bauer, Dagmar Rudzki, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|March 11, 2009
[Transdermal rivastigmine patch in outpatient services in Austria: a naturalistic study in 103 patients with Alzheimer dementia]Reinhold Schmidt, Claude Alf, Christian Bancher, et al.
Neurology|July 3, 2023
Diagnostic Performance of Adding the Optic Nerve Region Assessed by Optical Coherence Tomography to the Diagnostic Criteria for Multiple SclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
European Journal of Neurology|January 31, 2023
Retinal layer thickness predicts disability accumulation in early relapsing multiple sclerosisGabriel Bsteh, Harald Hegen, Patrick Altmann, et al.
Multiple Sclerosis and Related Disorders|April 25, 2023
Screening for osteoporosis in people with MS: A new risk scoreAnne Zinganell, Harald Hegen, Janette Walde, et al.
Annals of Clinical and Translational Neurology|December 17, 2024
Retinal thinning differentiates treatment effects in relapsing multiple sclerosis below the clinical thresholdGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 7, 2024
Retinal layer thinning for monitoring disease-modifying treatment in relapsing multiple sclerosis-Evidence for applying a rebaselining conceptGabriel Bsteh, Harald Hegen, Nik Krajnc, et al.
Pageof 10